| Cambridge Innovation Capital plc. (6/21/19). "Press Release: Annual Results for the Year Ended 31 March 2019". |
2019-06-21 |
| Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. |
2019-06-20 |
| BioCity Group Ltd.. (6/18/19). "Press Release: New Carbon Capture Technology Could Help Industry and Agricultural Sector Decarbonise". |
2019-06-18 |
| GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. |
2019-06-13 |
| Medicines Discovery Catapult, The. (6/12/19). "Press Release: Bringing the Benefits of Cutting-edge Mass Spectrometry Technologies to UK SMEs. Medicines Discovery Catapult and Waters Partner". |
2019-06-12 |
| Ligand Pharmaceuticals Inc.. (6/12/19). "Press Release: Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology". San Diego, CA & Cambridge. |
2019-06-12 |
| Exscientia Ltd.. (6/11/19). "Press Release: Exscientia Expands International Collaborations with Shanghai-headquartered GT Apeiron Therapeutics". Oxford. |
2019-06-11 |
| Sphere Fluidics Ltd.. (6/10/19). "Press Release: Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round". Cambridge. |
2019-06-10 |
| Sanofi S.A.. (6/7/19). "Press Release: Paul Hudson to Succeed Olivier Brandicourt as Chief Executive Officer". Paris. |
2019-06-07 |
| BioCity Group Ltd.. (6/7/19). "Press Release: New Contract Research Organisation for Platelet Testing". |
2019-06-07 |
| Yukin Therapeutics S.A.S.. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. |
2019-06-04 |
| University of Warwick. (5/31/19). "Press Release: Disruptive 2D Mass Spectrometry Spin-out Secures Seed Investment". |
2019-05-31 |
| Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London. |
2019-05-30 |
| [iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme |
2019-05-30 |
| BRAIN AG. (5/29/19). "Press Release: BRAIN AG Achieves Significant Growth in the First Half of the 2018/19 Financial Year". Zwingenberg. |
2019-05-29 |
| Oxford BioMedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford. |
2019-05-28 |
| Satellite Applications Catapult. (5/23/19). "Press Release: Innovative Partnership to Embed the Power of Satellite Technology in Digitally Enabled Care". |
2019-05-23 |
| King’s College London. (5/20/19). "Press Release: Quell Therapeutics Ltd Founded for Emerging Area of Cell Therapy". |
2019-05-20 |
| LifeArc. (5/20/19). "Press Release: LifeArc Monetises Keytruda Royalty Interests to Fund further Research and Investment". |
2019-05-20 |
| Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with Wew Investor, Seroba Life Sciences". Cambridge. |
2019-05-20 |
| Biosynth AG. (5/20/19). "Press Release: Biosynth and Carbosynth Merge to Form a Leading Player in the Global Fine Chemicals Market". Staad & Compton. |
2019-05-20 |
| Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. |
2019-05-20 |
| ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford. |
2019-05-15 |
| MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency". London & New York, NY. |
2019-05-14 |
| Sekisui Diagnostics, LLC. (5/14/19). "Press Release: Sekisui Diagnostics Invests $1.9 Million in Microbial Biopharma CDMO Business". Lexington, MA. |
2019-05-14 |
| MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. |
2019-05-14 |
| F-Star Biotechnology Ltd.. (5/14/19). "Press Release: F-star Expedites Its Transition to a Wholly-owned Portfolio Strategy". Cambridge. |
2019-05-14 |
| TreeFrog Therapeutics S.A.S.. (5/13/19). "Press Release: TreeFrog Therapeutics Raises over €7M ($7.8M) in Series A Financing Round 6 Months after Incorporation". Bordeaux. |
2019-05-13 |
| Philogen S.p.A.. (5/13/19). "Press Release: Philogen Announces €62 Million Financing Round". Siena. |
2019-05-13 |
| MeiraGTx Holdings plc. (5/10/19). "Press Release: MeiraGTx Appoints Nicole Seligman to Board of Directors". London & New York, NY. |
2019-05-10 |
| Immunocore Ltd.. (5/7/19). "Press Release: Immunocore Appoints Dr Mohammed Dar as Head of Clinical Development and Chief Medical Officer". Oxfordshire, Pennsylvania & Maryland. |
2019-05-07 |
| High-Tech Gründerfonds Management GmbH. (5/7/19). "Press Release: Drug Discovery Technology Start-up DyNAbind Secures Seed Financing". |
2019-05-07 |
| Transgene S.A.. (5/2/19). "Press Release: Transgene and AstraZeneca Enter into a Collaboration and Exclusive License Option Agreement for Innovative Invir.IO based Armed Oncolytic Immunotherapies". Strasbourg. |
2019-05-02 |
| Mission Therapeutics Ltd.. (5/1/19). "Press Release: Dr. James Summers Appointed to Mission Therapeutics’ Board of Directors". Cambridge. |
2019-05-01 |
| Congenica Ltd.. (4/30/19). "Press Release: Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round". Cambridge. |
2019-04-30 |
| Enzyre B.V.. (4/30/19). "Press Release: Enzyre Appoints Dirk Pollet as Chief Executive Officer. Awarded €2M Grant and Completes Seed Financing". Nijmegen. |
2019-04-30 |
| Alentis Therapeutics AG. (4/30/19). "Press Release: Alentis Therapeutics Launches, Raising CHF 12.5m in a Series A to Develop Novel Therapeutics in Advanced Liver Disease and Cancer". Basel. |
2019-04-30 |
| Berlin Partner. (April 2019). "Special Feature: BIONNALE 2019 in Berlin – the Networking Event for the Life Sciences & Healthcare Industries in the German Capital Region". Berlin. |
2019-04-27 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. |
2019-04-26 |
| Merck KGaA. (4/26/19). "Press Release: Merck Presents Plans for Future Growth to Shareholders. 24th Annual General Meeting in Frankfurt am Main". Frankfurt a. M.. |
2019-04-26 |
| MeiraGTx Holdings plc. (4/25/19). "Press Release: MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019". London & New York, NY. |
2019-04-25 |
| Merck KGaA. (4/24/19). "Press Release: Merck Introduces New Greener Solvent, Cyrene". Darmstadt. |
2019-04-24 |
| BioCity Group Ltd.. (4/24/19). "Press Release: BioCity Invests in Carbon Recycling Start-up, Deep Branch Biotechnology". |
2019-04-24 |
| ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. |
2019-04-23 |
| Bio-Rad Laboratories, Inc.. (4/22/19). "Press Release: Bio-Rad Appoints Andrew Last as Executive Vice President and Chief Operating Officer". Hercules, CA. |
2019-04-22 |
| Poseida Therapeutics, Inc.. (4/22/19). "Press Release: Poseida Therapeutics Raises $142 Million in Series C Financing". San Diego, CA. |
2019-04-22 |
| [iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. |
2019-04-17 |
| PureTech Health plc. (4/17/19). "Press Release: PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates Using Its Lymphatic Targeting Platform". Boston, MA. |
2019-04-17 |
| Inivata Ltd.. (4/16/19). "Press Release: Inivata, Thermo Fisher Scientific, and Genomics England Successfully Complete First Phase of Study Assessing Plasma Samples and Potential of Liquid Biopsy". |
2019-04-16 |
| Biotechpharma UAB. (4/16/19). "Press Release: Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000L". Vilnius. |
2019-04-16 |
| Catalent, Inc.. (4/15/19). "Press Release: Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion". Somerset, NJ & Baltimore, MD. |
2019-04-15 |
| bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile. |
2019-04-14 |
| BioStrata Ltd.. (4/11/19). "Press Release: BioStrata Launches Targeted News Distribution Service for Life Science and Healthcare Companies". Cambridge. |
2019-04-11 |
| Igem Therapeutics Ltd.. (4/9/19). "Press Release: Igem Therapeutics Appoints Dr David Chiswell as a Non-Executive Chairman". London. |
2019-04-09 |
| Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. |
2019-04-08 |
| Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. |
2019-04-08 |
| Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm. |
2019-04-05 |
| Crescendo Biologics Ltd.. (4/4/19). "Press Release: Theodora Harold to Be Appointed New CEO at Crescendo Biologics". Cambridge. |
2019-04-04 |
| Curetis N.V.. (4/4/19). "Press Release: Study Data Presented at ECCMID 2019 Confirm Clinical Benefits of Unyvero Platform". Amsterdam, San Diego, CA & Holzgerlingen. |
2019-04-04 |
| Exscientia Ltd.. (4/3/19). "Press Release: Exscientia Achieves Molecule Discovery Milestone as Part of GSK Collaboration". Oxford. |
2019-04-03 |
| ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. |
2019-04-03 |
| Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. |
2019-04-01 |
| Congenica Ltd.. (4/1/19). "Press Release: Congenica Announces On-Premise Deployment Option for its Sapientia Platform". Cambridge. |
2019-04-01 |
| Evotec SE. (4/1/19). "Press Release: Evotec AG Completes Conversion into Evotec SE". Hamburg. |
2019-04-01 |
| Cell Mogrify Ltd.. (4/1/19). "Press Release: Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic". Cambridge. |
2019-04-01 |
| Karuna Therapeutics, Inc.. (4/1/19). "Press Release: Karuna Completes $80 Million Series B Financing". Boston, MA. |
2019-04-01 |
| Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. |
2019-04-01 |
| Mologic Ltd.. (4/1/19). "Press Release: Mologic Expands US and UK Operations. Strengthens Team as Part of Continued International Expansion – Bolsters US Presence with the Opening of Subsidiary in Boston, MA". Bedfordshire. |
2019-04-01 |
| ArcherDX, Inc.. (3/28/19). "Press Release: ArcherDX Announces Collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients". Boulder, CO. |
2019-03-28 |
| Evotec AG. (3/28/19). "Press Release: Evotec AG Fiscal Year 2018 Results – Accelerated Growth and Strong Long-term Outlook". Hamburg. |
2019-03-28 |
| Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. |
2019-03-28 |
| Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. |
2019-03-28 |
| Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. |
2019-03-27 |
| Sphere Fluidics Ltd.. (3/26/19). "Press Release: Sphere Fluidics Hires 10 New UK and US Staff in Its Plan to Scale Internationally". Cambridge. |
2019-03-26 |
| MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. |
2019-03-26 |
| Evaluate Ltd.. (3/26/19). "Press Release: Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer". London, Boston, MA & Tokyo. |
2019-03-26 |
| F-Star Biotechnology Ltd.. (3/25/19). "Press Release: F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting". Cambridge. |
2019-03-25 |
| Exscientia Ltd.. (3/22/19). "Press Release: Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia". Oxford & Osaka. |
2019-03-22 |
| Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. |
2019-03-21 |
| Exscientia Ltd.. (3/21/19). "Press Release: Celgene and Exscientia Enter 3-year AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity". Oxford. |
2019-03-21 |
| Cambridge Cancer Genomics Ltd.. (3/21/19). "Press Release: Genomics England and Cambridge Cancer Genomics (CCG.ai) Announce Immunotherapy Partnership". Cambridge. |
2019-03-21 |
| Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. |
2019-03-21 |
| NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". |
2019-03-20 |
| Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. |
2019-03-19 |
| Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. |
2019-03-18 |
| Cell Mogrify Ltd.. (3/18/19). "Press Release: Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies". Cambridge. |
2019-03-18 |
| Karuna Therapeutics, Inc.. (3/18/19). "Press Release: Karuna Announces $68 Million Series B Financing". Boston, MA. |
2019-03-18 |
| Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. |
2019-03-18 |
| AstraZeneca plc. (3/14/19). "Press Release: AstraZeneca Showcases Next-generation Oncology Pipeline Addressing Unmet Patient Needs at AACR Annual Meeting". |
2019-03-14 |
| Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. |
2019-03-14 |
| CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. |
2019-03-14 |
| Oxford BioMedica plc. (3/12/19). "Press Release: Oxford Biomedica Announces R&D Collaboration with Microsoft to Improve Gene and Cell Therapy Manufacturing Using the Intelligent Cloud and Machine Learning". Oxford. |
2019-03-12 |
| Seres Therapeutics, Inc.. (3/11/19). "Press Release: Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca". Cambridge, MA. |
2019-03-11 |
| Owlstone Medical Ltd.. (3/7/19). "Press Release: University of Manchester and Owlstone Medical Partner on £250,000 Grant from Asthma UK and Innovate UK for Asthma Diagnostic Development". Manchester & Cambridge. |
2019-03-07 |
| Moderna, Inc.. (3/6/19). "Press Release: Moderna Reports 2018 Fourth Quarter and Full Year Financial Results and Highlights Recent Pipeline Progress". Cambridge, MA. |
2019-03-06 |
| Agilent Technologies Inc.. (3/6/19). "Press Release: Agilent and Imperial College London Strengthen Partnership". Santa Clara, CA. |
2019-03-06 |
| Algenex S.L.. (3/5/19). "Press Release: Algenex Closes Funding Round and Strengthens Team with Key Senior Manager Appointments". Madrid. |
2019-03-05 |
| Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. |
2019-03-05 |
| Huntsworth plc. (3/5/19). "Press Release: Audited Preliminary Results for the Year Ended 31 December 2018". |
2019-03-05 |
| Nightstar Therapeutics plc. (3/4/19). "Press Release: Nightstar Therapeutics plc Reaches Agreement to Be Acquired by Biogen". |
2019-03-04 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo-2019.png){kind=logo}
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
